A. Mesropian Badalian, A. Gris-Oliver, J. Abril-Fornaguera, M. Piqué-Gili, M. Torres-Marcén, D. Camell-Raventós, J. Peix, E. Fernández-Martínez, U. Balaseviciute, J. Huguet-Pradell, I. Keraite, R. Esteban-Fabró, R. Pinyol, M. Bárcena-Varela, K.E. Lindblad, A. Lujambio, E. Guccione, S.N. Thung, D. Sia, J.M. Llovet
{"title":"76(PB064):E7386可增强来伐替尼和抗PD1对HCC的抗肿瘤活性","authors":"A. Mesropian Badalian, A. Gris-Oliver, J. Abril-Fornaguera, M. Piqué-Gili, M. Torres-Marcén, D. Camell-Raventós, J. Peix, E. Fernández-Martínez, U. Balaseviciute, J. Huguet-Pradell, I. Keraite, R. Esteban-Fabró, R. Pinyol, M. Bárcena-Varela, K.E. Lindblad, A. Lujambio, E. Guccione, S.N. Thung, D. Sia, J.M. Llovet","doi":"10.1016/j.ejca.2024.114603","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":null,"pages":null},"PeriodicalIF":7.6000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"76 (PB064): E7386 enhances both lenvatinib and anti-PD1 antitumor activity in HCC\",\"authors\":\"A. Mesropian Badalian, A. Gris-Oliver, J. Abril-Fornaguera, M. Piqué-Gili, M. Torres-Marcén, D. Camell-Raventós, J. Peix, E. Fernández-Martínez, U. Balaseviciute, J. Huguet-Pradell, I. Keraite, R. Esteban-Fabró, R. Pinyol, M. Bárcena-Varela, K.E. Lindblad, A. Lujambio, E. Guccione, S.N. Thung, D. Sia, J.M. Llovet\",\"doi\":\"10.1016/j.ejca.2024.114603\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11980,\"journal\":{\"name\":\"European Journal of Cancer\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":7.6000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0959804924012942\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0959804924012942","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
期刊介绍:
The European Journal of Cancer (EJC) serves as a comprehensive platform integrating preclinical, digital, translational, and clinical research across the spectrum of cancer. From epidemiology, carcinogenesis, and biology to groundbreaking innovations in cancer treatment and patient care, the journal covers a wide array of topics. We publish original research, reviews, previews, editorial comments, and correspondence, fostering dialogue and advancement in the fight against cancer. Join us in our mission to drive progress and improve outcomes in cancer research and patient care.